BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas-Pfaab M, Annereau JP, Munsch C, Guilbaud N, Garrido I, Paul C, Brousset P, Lamant L, Meyer N. CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans. J Dermatol Sci 2013;69:105-13. [PMID: 23219141 DOI: 10.1016/j.jdermsci.2012.11.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Long E, Ilie M, Bence C, Butori C, Selva E, Lalvée S, Bonnetaud C, Poissonnet G, Lacour JP, Bahadoran P, Brest P, Gilson E, Ballotti R, Hofman V, Hofman P. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness. Cancer Med 2016;5:1022-30. [PMID: 26945789 DOI: 10.1002/cam4.661] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
2 Kuk SK, Won CH, Lee WJ, Shin WJ, Yoon HJ, Hong SD, Hong SP, Lee J Il. Prognostic significance of nestin in primary malignant melanoma of the oral cavity. Melanoma Res 2016;26:457-63. [PMID: 27223497 DOI: 10.1097/CMR.0000000000000265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Guanziroli E, Venegoni L, Fanoni D, Cavicchini S, Coggi A, Ferrero S, Gianotti R, Berti E, Del Gobbo A. Immunohistochemical expression and prognostic role of CD10, CD271 and Nestin in primary and recurrent cutaneous melanoma. Ital J Dermatol Venerol 2021;156:68-72. [PMID: 30251808 DOI: 10.23736/S2784-8671.18.06145-X] [Reference Citation Analysis]
4 Naik PP. Role of Biomarkers in the Integrated Management of Melanoma. Dis Markers 2021;2021:6238317. [PMID: 35003391 DOI: 10.1155/2021/6238317] [Reference Citation Analysis]
5 Madjd Z, Erfani E, Gheytanchi E, Moradi-Lakeh M, Shariftabrizi A, Asadi-Lari M. Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis. Int J Biol Markers 2016;31:e118-25. [PMID: 27102864 DOI: 10.5301/jbm.5000209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
6 Meng F, DeMorrow S, Venter J, Frampton G, Han Y, Francis H, Standeford H, Avila S, McDaniel K, McMillin M, Afroze S, Guerrier M, Quezada M, Ray D, Kennedy L, Hargrove L, Glaser S, Alpini G. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol 2014;306:G759-68. [PMID: 24603459 DOI: 10.1152/ajpgi.00018.2014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
7 Belter B, Haase-kohn C, Pietzsch J; Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, Department of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany. Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective. In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy. Codon Publications; 2017. pp. 39-56. [DOI: 10.15586/codon.cutaneousmelanoma.2017.ch3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Sankhe R, Pai SRK, Kishore A. Tumour suppression through modulation of neprilysin signaling: A comprehensive review. Eur J Pharmacol 2021;891:173727. [PMID: 33160935 DOI: 10.1016/j.ejphar.2020.173727] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Sankhe R, Rathi E, Manandhar S, Kumar A, Pai SRK, Kini SG, Kishore A. Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study. J Mol Struct 2021;1224:129073. [PMID: 32834116 DOI: 10.1016/j.molstruc.2020.129073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]